Latent Secures $80M Series A Funding to Enhance Access to Life-Saving Medications

Clinical-AI company Latent raises substantial funds to improve medication access and forms key partnerships with top U.S. health systems

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here